ATC were harvested and armed with CD20Bi or EGFRBi to target CD20 positive Burkitt’s lymphoma cell line (Daudi) or EGFR positive pancreatic cancer cell line (COLO356/FG), respectively. The gene discussed is EGFR; the disease is familial pancreatic carcinoma.